Skip to main content
  • NIH Aug 13, 2019 | R21

    Developing Clinical Translational Tools to Communicate Genetic Risk to Individuals who are at Clinical High Risk for Psychosis

    Principal Investigator(s): YANG, LAWRENCE H;

    Institution: NEW YORK UNIVERSITY

    FOA Number: PA-18-344

    Abstract

    While great strides are being made in identifying early signs that place people at a ?high risk state? for different illness conditions, at the same time, advances are being made in the identification of genes associated with ?high-risk states?. This study proposes to develop two innovative clinical tools that could greatly facilitate dissemination of a beneficial genetic malleability framing to high-risk youth in order to encourage increased treatment engagement and uptake of healthy behaviors. The impact of genetic information assumes special importance in the ?high-risk state? because achieving the best possible outcome is more likely if individuals actively choose to engage in beneficial treatment and health-promoting behaviors.

    FUNDING AGENCY:

    Funder:
    NIH

    Institute:
    NATIONAL HUMAN GENOME RESEARCH INSTITUTE

    Funding Type:
    R21

    Project Number:
    R21HG010420

    Start Date:
    Aug 13, 2019

    End Date:
    Jul 31, 2021

    PROJECT TERMS:

Share

Related Projects

+ Show more related project Search results